Safety and Efficacy of Upfront Plerixafor + G-CSF vs. Placebo + G-CSF for Mobilization of CD34(+) Hematopoietic Progenitor Cells in Patients ≥60 and <60 Years of Age with Non-Hodgkin’s Lymphoma or Multiple Myeloma

The efficacy and safety of plerixafor + G-CSF in enhancing hematopoietic stem cell mobilization and collection has been demonstrated in two phase III studies involving patients with NHL or MM. In these pivotal studies, plerixafor + G-CSF significantly increased the proportion of patients achieving t...

Full description

Saved in:
Bibliographic Details
Published in:Am J Hematol
Main Authors: Micallef, Ivana N., Stiff, Patrick J., Stadtmauer, Edward A., Bolwell, Brian J., Nademanee, Auayporn P., Maziarz, Richard T., Partisano, Angela M., Marulkar, Sachin, DiPersio, John F.
Format: Artigo
Language:Inglês
Published: 2013
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4295654/
https://ncbi.nlm.nih.gov/pubmed/23907769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23561
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items